Bioton S.A. Logo

Bioton S.A. (BIO)

GPW

Currency in PLN
3.77
-0.05 (-1.18%)

Real-time Data

07:00 AM

Day's Range

3.68
3.83

52 wk Range

3.65
4.60

Overview - BIO - Bioton S.A.

Key Statistics

Valuation

Enterprise Value

379.84M

P/E (Trailing)

‪75.40‬

PEG Ratio

‪4.83‬

Price / Sales (TTM)

‪1.21‬

Price / Book

‪0.54‬

EV / EBITDA

‪7.27‬

Profitability

Gross Margin

‪29.49%‬

Profit Margin

‪1.52%‬

Operating Margin

‪-8.39%‬

Return on Assets

‪1.08%‬

Return on Equity

‪0.69%‬

Ownership

Shares Outstanding

85.86M

Float

38.79M

Held by Insiders

‪56.30%‬

Held by Institutions

‪0.27%‬

Price stats

Beta

‪0.17‬

50-Day Avg

‪3.88‬

200-Day Avg

‪4.05‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - BIO - Bioton S.A.

Peers - BIO - Bioton S.A.

Profile Summary - BIO - Bioton S.A.

About

Bioton S.A. is a Polish biotechnology company specializing in the development, manufacturing, and distribution of recombinant human insulin and generic pharmaceuticals. Headquartered in Macierzysz near Warsaw, the company is among the first four organizations globally capable of producing recombinant human insulin, a…

SectorHealthcare
IndustryBiotechnology
Employees361
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.